0% READ
FULL TEXT
INTRODUCTION
Standardization refers to a procedure that includes the examination, validation, preservation, and enhancement of the quality, effectiveness, safety, and consistency of a medicinal substance within a complex infrastructure. It has been suggested that nearly 80% of pharmaceutical products are derived from natural sources (Kunle, 2012). Significant advancements have been observed in the Ayurvedic and herbal Research and Development (R&D) sector over the past few decades (Bhattacharya, 2019). Nevertheless, only a limited number of Indian pharmaceutical companies are engaging in the standardization of herbal medicinal products using advanced instrumentation (Sardana, 2012).
The Amarantha Gynorite capsule and syrup are proprietary Ayurvedic formulations created and produced by Ari Healthcare Private Limited, Pune, India, aimed at managing various menstrual issues such as dysmenorrhea, hypomenorrhea, oligomenorrhea, amenorrhea, menorrhagia, metrorrhagia, menometrorrhagia, dysfunctional uterine bleeding, and Polyendocrine Metabolic Ovarian Syndrome (PMOS). Both products include standardized hydroalcoholic extracts of Ashoka bark (Saraca indica Linn.), Vasa leaf (Adhatoda vasica Nees.), Bijaka stem (Pterocarpus marsupium Roxb.), and a mixture known as Trikatu (composed of Zingiber officinale, Piper nigrum, and Piper longum in equal ratios) as their primary ingredients, along with additional components. The key marker compounds that significantly contribute to the pharmacological effects of these formulations are Vasicine (VS), Gallic Acid (GA), Piperine (PP), and Pterostilbene (PTS) (Katole et al., 2021; Vidyasagar & Prashantkumar, 2006).
Vasicine, also known as peganine, is a type of quinazoline alkaloid and a chemical marker found in Adhatoda vasica Nees. Vasicine has activities that stimulate the uterus, reduce inflammation, provide antioxidant effects, and modulate the immune system. Gallic acid, or 3,4,5-trihydroxybenzoic acid, is one of the primary secondary metabolites in Saraca asoca Linn. Gallic acid is beneficial in treating uterine disorders, including bleeding and infections in uterine tissues. It also has anti-inflammatory and antioxidant properties. Piperine is an alkaloid present in Piper nigrum Linn. and Piper longum Linn. Piperine is known for its capability to enhance bioavailability, as well as its antioxidant, anti-inflammatory, antiplatelet, antihypertensive, hepatoprotective, and anticancer effects. It is effective in managing ovarian cancer, hypertension, and thyroid issues. Pterostilbene is a natural polyphenol that is a dimethyl ether derivative of resveratrol. Research has indicated that Pterostilbene is helpful in treating gynecological disorders, blood diseases, vascular problems, impaired insulin signaling, endometrial cancer, and ovarian cancer. Additionally, Pterostilbene aids in the regulation of gonadotropin hormone secretion (Bai et al., 2021; Karri, 2014; Chopra et al., 2016; Yu et al., 2021; Zhang et al., 2016; Ministry of AYUSH, n.d.).
High-Performance Thin Layer Chromatography (HPTLC) is a commonly used analytical method in herbal industries due to its low operational costs, high sample throughput, and minimal need for sample preparation. One of the key benefits of HPTLC is the ability to analyze multiple samples at once with a small volume of mobile phase, unlike High Performance Liquid Chromatography (HPLC), which helps reduce the time and cost associated with each analysis. The comparison of HPTLC chromatogram patterns appears to be a valuable approach for identifying the active compounds in plant extracts. In the course of reviewing the literature, there was no information found concerning the simultaneous analysis of VS, GA, PP, and PTS (Sachan et al., 2016; Attimarad et al., 2011; Garg et al., 2013; Tsering et al., 2014; International Council for Harmonisation [ICH], 2005).
To standardize the Amarantha Gynorite syrup and capsule, an effort was made to create a simultaneous determination of four distinct marker compounds utilizing the HPTLC method.
MATERIALS AND METHODS
Solvents & Chemicals
Solvents of analytical grade, including toluene, ethyl acetate, methanol, and glacial acetic acid, were acquired from Merck Life Science Pvt. Ltd., in Mumbai, India. The reference standards were obtained from Natural Remedies Ltd. in Bangalore, India. Table 1 contains the list of standards along with their respective potency.
| Sl. No. | Name of Standard | Batch Number | Purity (%) |
|---|---|---|---|
| 1. | Vasicine | T22E155 | 98.2 |
| 2. | Gallic Acid | T12K021 | 99.0 |
| 3. | Piperine | T13D040 | 98.0 |
| 4. | Pterostilbene | H220659 | 95.0 |
Investigational Products
Ayurvedic formulations (Amarantha Gynorite capsule and Amarantha Gynorite syrup) were manufactured and provided by Ari Healthcare Pvt. Ltd., Pune, India. The ingredients of Amarantha Gynorite capsule and Amarantha Gynorite syrup are mentioned in Tables 2 and 3, respectively.
| Sl. No. | Ingredient Name | Scientific Name | Quantity |
|---|---|---|---|
| 1. | Ashoka Bark Extract | Saraca indica Linn. | 150 mg |
| 2. | Kumari Leaf Extract | Aloe vera Tourn.ex Linn. | 75 mg |
| 3. | Pushyanuga Churna | Ayurvedic Classical Formulation | 50 mg |
| 4. | Bijaka Stem Extract | Pterocarpus marsupium Roxb. | 50 mg |
| 5. | Lodhra Bark Extract | Symplocos racemosa Roxb. | 50 mg |
| 6. | Tankana Bhasma | Ayurvedic Classical Formulation | 25 mg |
| 7. | Kasisa Bhasma | Ayurvedic Classical Formulation | 25 mg |
| 8. | Latakaranja Seed Extract | Caesalpinia bonducella (Linn.) Roxb. | 25 mg |
| 9. | Vasa Leaf Extract | Adhatodha vasica Nees. | 25 mg |
| 10. | Krishna Jeerak Fruit Extract | Carum carvi Linn. | 15 mg |
| 11. | Ajamoda Fruit Extract | Apium graveolens L. | 15 mg |
| 12. | Trikatu Extract | Ayurvedic Classical Formulation (Zingiber officinale, Piper nigrum, Piper longum) | 10 mg |
| Sl. No. | Ingredients | Latin Name | Quantity |
|---|---|---|---|
| 1. | Ashoka Bark Extract | Saraca indica Linn. | 150 mg |
| 2. | Kumari Leaf Extract | Aloe vera Tourn.ex Linn. | 75 mg |
| 3. | Pushyanug Churna | Ayurvedic Classical Formulation | 100 mg |
| 4. | Bijaka Stem Extract | Pterocarpus marsupium Roxb. | 50 mg |
| 5. | Lodhra Bark Extract | Symplocos racemosa Roxb. | 50 mg |
| 6. | Tankana Bhasma | Ayurvedic Classical Formulation | 25 mg |
| 7. | Kasisa Bhasma | Ayurvedic Classical Formulation | 25 mg |
| 8. | Latakaranja Seed Extract | Caesalpinia bonducella (Linn.) Roxb. | 25 mg |
| 9. | Vasa Leaf Extract | Adhatodha vasica Nees. | 25 mg |
| 10. | Krishna Jeerak Fruit Extract | Carum carvi Linn. | 15 mg |
| 11. | Ajamoda Fruit Extract | Apium graveolens L. | 15 mg |
| 12. | Trikatu Extract | Ayurvedic Classical Formulation (Zingiber officinale, Piper nigrum, Piper longum) | 10 mg |
HPTLC Instrumentation
HPTLC method development and validation was performed on CAMAG system. The details of instruments and specification are given in Table 4.
| Sl. No. | Components | Specification |
|---|---|---|
| 1. | Make and Model | CAMAG |
| 2. | Sample applicator | Linomat 5 |
| 3. | Scanner | TLC Scanner 4 |
| 4. | Chamber | Twin Trough chamber |
| 4. | Sampling mode | Linomat applicator (Manual) |
| 5. | Detection mode | Ultraviolet detector |
| 6. | Application Syringe | Hamilton (100µL) |
| 7. | Software | Wincats (Version_1.4.8.2031) |
Preparation of Solution
Preparation of Standard Solutions
Stock solutions of VS standard were created by dissolving 10.0 mg of VS in 10 mL of methanol, resulting in a concentration of 1.0 mg/mL. A working standard concentration of 100 µg/mL was generated by diluting 1 mL of the stock solution to 10 mL with methanol. Serial dilutions were made by measuring 0.5, 1.0, 2.0, 3.0, 4.0, 5.0, 6.0, 7.0, 8.0, 9.0, and 10.0 mL of the working standard solution and adding methanol to achieve a total volume of 10 mL for standards containing 5, 10, 15, 20, 30, 40, and 50 μg/mL respectively. Likewise, working standard concentrations (100 μg/mL) for GA, PP, and PTS were prepared by dissolving 10 mg of each individual standard in 100 mL of methanol. A series of dilutions were conducted in the same way as with VS to achieve final concentrations ranging from 5-50 μg/mL.
Preparation of Sample Solutions
Sample solutions were created by placing 250 mg of Amaranth Gynorite capsule powder and 1000 mg of Amaranth Gynorite syrup solution into a 100 mL volumetric flask. Then, 50 mL of methanol was added, and the mixture was subjected to sonication in a bath sonicator for 30 min at room temperature. The flask was subsequently filled to the mark with methanol, and the extract was filtered using Whatman filter paper. The resultant filtrates were utilized as the sample solutions for the respective formulations.
Percentage Assay of Standard Solution from Formulations and Herbal Extracts
Amarantha Gynorite syrup, Amarantha Gynorite capsule and herbal extracts were analyzed to determine the contents of VS, GA, PP and PTS as per method described under chromatographic conditions using HPTLC. Every single analysis was repeated three times and results were expressed in percent assay.
Method Validation
The HPTLC method that was developed underwent validation in accordance with the guidelines established by the International Council on Harmonization (ICH) Q2 (R1). All measurements were conducted in triplicate, with the following details provided.
Specificity
In line with the revised ICH Q2 (R1), specificity testing is essential to verify identification tests, assess impurities, and conduct the assay. During the specificity testing, specificity densitograms were generated for calibration curve [Figure 1], the standards, blank, and placebo formulations [Figures 2-4]. No interference with the analyte was observed [Figure 5].
Linearity
According to ICH guidelines, a minimum of five concentrations is required to establish linearity. Linearity is indicated by the correlation coefficient, y-intercept, and slope of the regression line, along with a visual representation of the data. Linearity was assessed within the concentration range of 5-50 μg/mL for VS, GA, PP, and PTS [Figure 6]. The relationship between peak area and concentration was analyzed using least square linear regression, determining the slope, intercept, and correlation coefficient for the calibration. The acceptable standard is an R² value of ≥ 0.99.
Precision
The evaluation of repeatability was conducted by utilizing a minimum of 9 measurements that encompass the specified range for the procedure (for example, 3 concentrations with 3 replicates each). Three replicate analyses were carried out at three varying concentration levels, specifically low (LQC: 50 μg/mL), medium (MQC: 100 μg/mL), and high (HQC: 150 μg/mL) for VS, during the same day at three different time points (Session 1, 2, 3). Intermediate precision was determined to examine the influence of random occurrences, such as different days, on the precision of the analytical method. Intraday and interday precision assessments were conducted by taking 9 measurements of 3 concentrations with 3 replicates each, at 3 time points on the same day and over 3 separate days, respectively. The aforementioned procedures were similarly repeated for GA, PP, and PTS. The accepted criterion was that the Relative Standard Deviation (RSD) should be ≤ 2%.
LOD & LOQ
The detection limit and quantification limit were established using the standard deviation of the response and the slope. Limit of Detection (LOD) is calculated as 3.3×σ/S. Limit of Quantification (LOQ) is calculated as 10×σ/S. Here, σ represents the standard deviation of the response estimated from the calibration curve, while S denotes the slope of the calibration curve. The values for LOD and LOQ were determined based on the standard deviation of the response and the slope of the calibration graph.
Accuracy
Accuracy was determined throughout the defined range of the analytical method by incorporating known quantities of the analyte into a synthetic mixture of drug product components and the combined dosage form. According to ICH guidelines, accuracy must be evaluated using at least 9 measurements across a minimum of three concentration levels that encompass the specified range, which means 3 concentration levels tested in triplicate (i.e., 3 concentrations, each replicated 3 times). The accuracy of the method is expressed as the percentage recovery of the known amount of analyte added to the sample. Accuracy should be indicated by the percentage recovery determined by assaying the known amount of analyte in the sample. Accuracy must be assessed using a minimum of 9 determinations spread across 3 concentration levels that cover the specified range. In this study, percentage recovery was computed by executing recovery tests in triplicate at three concentration levels: 80%, 100%, and 120%, by adding known amounts of standard solutions of vasicine, gallic acid, piperine, and pterostilbene. The samples were subsequently analyzed, and the obtained results were compared with the expected values. The acceptable criteria for recovery were determined to be between 98% and 102%.
Robustness
The robustness of the analytical method was assessed to demonstrate its reliability amid intentional changes in method parameters. The evaluation of robustness aimed to validate the dependability of the analytical technique concerning deliberate variations in various method parameters. To determine the robustness of the analytical method, the following factors were examined: modifications in the mobile phase ratio and changes in chamber saturation time. The acceptable criteria set for these evaluations was a pooled Relative Standard Deviation (RSD) of ≤ 3% for each change examined.
Stability testing (Intraday and Interday Assessments)
The stability of the sample solutions was evaluated over various time periods, including intraday (after 6 and 12 hr) and interday (after 24 hr), by storing them separately at 4°C and 25°C. The assessment of stability involved comparing the chromatographic attributes of the stored solutions with those of freshly prepared solutions, thereby covering both intraday and interday evaluations.
Statistical Analysis
Data were expressed as mean ± SD, and linear regression was used for calibration.
RESULTS
Section of Absorbance
The absorbance for each standard solution, namely VS, GA, PP, and PTS, was measured by scanning within the 400-200 nm range. All standard absorbance readings exhibited an isosbestic point, which was utilized for simultaneous analysis. The combined UV spectra of the four compounds displayed an isosbestic point at 290 nm. Consequently, 290 nm was chosen as the wavelength for the analysis. The specifics are illustrated in Figure 7.
Analytical Method Development
Optimization of chromatographic conditions: Based on the polarity and solubility of VS, GA, PP, and PTS, numerous preliminary experiments were conducted to select the mobile phase. The details of these trials are shown in Table 5. For the HPTLC method, the chromatographic parameters were fine-tuned to achieve optimal resolution and peak shape for VS, GA, PP, and PTS. Various mobile phases in different ratios were tested, and a mobile phase composed of toluene: ethyl acetate: methanol: glacial acetic acid [7:3:1:1.5] (v/v/v/v) was chosen as the best option for obtaining well-resolved bands of VS, GA, PP, and PTS, as listed in Table 6.
| Trial. No. | Mobile Phase | Composition Ratio (v/v/v/v) | Applied Volume (µL) | Observation |
|---|---|---|---|---|
| 1 | Tol: EA: FA | 7:3:0.5 | 5,10, 15 & 20 | All bands were observed except Vasicine. |
| 2 | Tol: EA: MeOH: FA | 8:3:1.5:2 | 5 & 10 | All bands were observed except Vasicine. |
| 3 | EA: MeoH: Diethyl Amine | 6:1:0.5 | 5 & 10 | All bands were observed except Gallic acid. Injection volume was optimized. |
| 4 | Choloform: MeOH | 8:2 | 10 | Only two bands were detected i.e Piperine and Pterostilbene |
| 5 | Tol: EA: MeOH: Diethyl Amine | 7: 3: 1: 1.5 | 10 | All bands were observed except Gallic acid. |
| 6 | Tol: EA: MeOH | 6: 3:1 | 10 | All four bands were detected but its shows tailing. Mobile phase compositions have to optimize for better separations. |
| 7 | Tol: EA: MeOH: GAA | 7: 4: 1: 1.5 | 10 | All bands were detected but Piperine and Pterostilbene overlaying each other Hence mobile phase have to optimize. |
| 8 | Tol: EA: MeOH: GAA | 7: 3: 1: 1.5 | 10 | All bands are well separated |
| Sl. No. | Parameters | Optimized chromatographic conditions |
|---|---|---|
| 1. | Stationary Phase | Precoated silica gel aluminum plate G 60 F254 |
| 2. | Plate and Chamber size | 10 X 10 and 10 X 20 |
| 3. | Mobile Phase compositions | Tol: EA: MeOH: GAA (7:3:1:1.5 v/v/v/v) |
| 4. | Chamber saturation time | 30 min |
| 5. | Sample application a) Application volume b) Band Length c) Distance between the tracks | 10 µL 6 mm 10 mm |
| 6. | Temperature (°C) | 25-28 |
| 7. | Relative humidity (%) | 55-60 |
| 8. | Technique of separation | Ascending |
| 9. | Detection wavelength | 290 nm |
Estimation of Marker compounds from Herbal Extracts and Ayurvedic formulations
The percent assay of VS, GA, PP, and PTS in herbal extracts (Vasa leaf, Ashoka bark, Trikatu, and Bijaka stem) and formulations (Amarantha Gynorite syrup and capsule) was calculated using a formula. Results are presented in Table 7.
| Sl. No. | Standards | Extracts (% Assay) | Gynorite Syrup (% Assay) | Gynorite Capsule (% Assay) |
|---|---|---|---|---|
| 1. | VS | 1.12 | 0.81 | 0.64 |
| 2. | GA | 1.09 | 0.76 | 0.58 |
| 3. | PP | 1.61 | 0.98 | 0.45 |
| 4. | PTS | 2.12 | 1.07 | 1.27 |
For Extracts

For Formulation

Specificity
The specificity of the HPTLC method was demonstrated by separating the analyte from other potential components, including the blank and placebo of Amarantha Gynorite syrup and capsule. Application volume of 10 μL of potential components was injected and the densitogram was recorded [Figures 8 and 9]. Peaks of these components were not found at Rf of 0.11, 0.34, 0.68 and 0.71 of VS, GA, PP and PTS [Figures 2-4 and Figures 10-12]. Hence, the proposed method was specific.
Linearity
The calibration graph displayed a linear relationship within the concentration range of 5-50 μg/mL. The linearity was confirmed by analyzing the regression line and evaluating the Regression coefficient (R2). The linear regression data for the calibration curve can be found in Table 8.
| Sl. No. | Parameter | Results | |||
|---|---|---|---|---|---|
| VS | GA | PP | PTS | ||
| 1. | Linearity Range (μg/mL) | 5 - 50 | 5 - 50 | 5 - 50 | 5 - 50 |
| 2. | Correlation coefficient (R2) | 0.9958 | 0.9995 | 0.9966 | 0.9984 |
| 3. | y-intercept | 91.731 | 402.02 | 381.94 | 438.75 |
| 4. | Slope | 835.41 | 3182.2 | 897.81 | 780.11 |
Precision
Intraday Precision studies were conducted at three concentration levels (LQC, MQC, HQC) within the same day at different intervals. Details are mentioned in Table 9. Inter-day Precision studies were performed on three consecutive days using the same homogeneous sample and are listed in Table 10. The results were statistically analyzed for standard deviation and percent relative standard deviation (coefficient of variance), with a percentage RSD of peak areas less than 2%, indicating the developed method's precision.
| VS | GA | PP | PTS | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQC | MQC | HQC | LQC | MQC | HQC | LQC | MQC | HQC | LQC | MQC | HQC | |
| Amount (µg/mL) | 50 | 100 | 150 | 50 | 100 | 150 | 50 | 100 | 150 | 50 | 100 | 150 |
| Peak Area | 4853.8 | 9918.4 | 15311.8 | 22430.8 | 45961.9 | 68608.4 | 20304.7 | 39083.3 | 59674.2 | 21362.9 | 45126.2 | 67689.3 |
| 4818.4 | 9814.9 | 15221.2 | 22312.6 | 44918.4 | 68657 | 20126.2 | 38464.2 | 59890.5 | 21864.2 | 46023.6 | 67135.3 | |
| 4920.4 | 10008 | 15134.5 | 22642.1 | 45226.4 | 68308.9 | 19892.1 | 39061.9 | 59183.5 | 21141.2 | 45412.5 | 68001.3 | |
| Average Peak Area | 4864.2 | 9913.9 | 15222.5 | 22461.8 | 45368.9 | 68524.7 | 20107.6 | 38869.8 | 59582.7 | 21456.1 | 45520.7 | 67608.6 |
| SD | 51.79 | 96.93 | 88.66 | 166.93 | 536.15 | 188.52 | 206.93 | 351.42 | 362.26 | 370.40 | 458.39 | 438.59 |
| % RSD | 1.06 | 0.977 | 0.582 | 0.743 | 1.181 | 0.275 | 1.029 | 0.904 | 0.608 | 1.726 | 1.006 | 0.648 |
| VS | GA | PP | PTS | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQC | MQC | HQC | LQC | MQC | HQC | LQC | MQC | HQC | LQC | MQC | HQC | |
| Amount (µg/mL) | 50 | 100 | 150 | 50 | 100 | 150 | 50 | 100 | 150 | 50 | 100 | 150 |
| Peak Area | 4798.3 | 9641.5 | 14023.6 | 21907.2 | 43701.2 | 65892.3 | 19454.1 | 38993.7 | 57520.5 | 20175.5 | 44676.3 | 65873.5 |
| 4753.1 | 9786.2 | 14345.5 | 21523.8 | 44052.6 | 65423.1 | 19821.8 | 38179.3 | 57240.8 | 20631.1 | 43987.6 | 66159.6 | |
| 4890.5 | 9741.3 | 14535.2 | 21646.1 | 44121.2 | 67404.2 | 19907.7 | 38806.5 | 58741.3 | 20421.3 | 44253.6 | 66371.8 | |
| Average Peak Area | 4813.96 | 9723 | 4301.4 | 21692.3 | 43958.3 | 66239.8 | 19727.8 | 38659.8 | 57834.2 | 20409.3 | 44305.8 | 66134.9 |
| SD | 70.02 | 74.06 | 258.63 | 195.8 | 225.31 | 1035.27 | 240.94 | 426.55 | 797.9 | 228.03 | 347.30 | 250.06 |
| % RSD | 1.45 | 0.76 | 1.80 | 0.91 | 0.512 | 1.57 | 1.22 | 1.10 | 1.37 | 1.11 | 0.783 | 0.378 |
Limit of Detection & Quantification
The limit of detection and quantification were determined based on the standard deviation of the response and the slope of regression line. The calculated values of Limit of Detection (LOD) and Limit of Quantitation (LOQ) for vasicine, gallic acid, piperine and pterostilbene are shown in Table 11.
| Sl. No. | Parameters | VS | GA | PP | PTS |
|---|---|---|---|---|---|
| 1. | LOD | 0.662 ng/mL | 1.573 ng/mL | 1.152 ng/mL | 1.688 ng/mL |
| 2. | LOQ | 2.018 ng/mL | 4.769 ng/mL | 3.492 ng/mL | 5.115 ng/mL |
Accuracy
Accuracy indicates the percent recovery of a known analyte amount in a sample. It was assessed through recovery studies in triplicates at three concentration levels: 80%, 100%, and 120% using vasicine, gallic acid, piperine, and pterostilbene. Results are shown in Table 12.
| Standard Solutions | Percent Level | Peak Area | % Recovery | Average % Recovery | %RSD |
|---|---|---|---|---|---|
| VS | 80 | 7541.1 | 100.73 | 100.21 | 1.076 |
| 100 | 10334.4 | 100.63 | |||
| 120 | 11411.2 | 99.28 | |||
| GA | 80 | 35154.5 | 99.28 | 99.96 | 1.093 |
| 100 | 45617.6 | 102.0 | |||
| 120 | 52600.3 | 98.60 | |||
| PP | 80 | 35008.7 | 98.88 | 100.66 | 0.9038 |
| 100 | 45189.8 | 101.49 | |||
| 120 | 54557.5 | 101.62 | |||
| PTS | 80 | 32632.4 | 98.42 | 99.28 | 1.15 |
| 100 | 37253.03 | 99.255 | |||
| 120 | 43797.4 | 100.15 |
Robustness
The robustness of the method was evaluated by making slight changes to chromatographic conditions, including mobile phase composition and chamber saturation time. A standard solution concentration of 10 μg/mL was applied in triplicate. The effects on the Retention factor (Rf) and peak area were assessed by calculating the (% RSD). The results indicated that the developed method is robust, as detailed in Table 13.
| Parameters | VS | GA | PP | PTS | ||||
|---|---|---|---|---|---|---|---|---|
| % RSD | ||||||||
| Rf | % RSD | Rf | % RSD | Rf | % RSD | Rf | % RSD | |
| Mobile Phase composition | ||||||||
| Tol: EA: MeOH: GAA (6:3:1:1.5) | 0.12 | 0.5199 | 0.34 | 0.685 | 0.73 | 0.78 | 0.76 | 1.12 |
| Tol: EA: MeOH: GAA (7:3:1:1.5) | 0.09 | 1.28 | 0.32 | 0.82 | 0.70 | 1.10 | 0.74 | 0.78 |
| Tol: EA: MeOH: GAA (7:4:1:1.5) | 0.10 | 0.536 | 0.33 | 1.18 | 0.71 | 0.82 | 0.75 | 0.84 |
| Saturation time (min) | ||||||||
| 28 | 0.10 | 1.36 | 0.32 | 1.14 | 0.70 | 1.12 | 0.74 | 0.85 |
| 30 | 0.10 | 1.28 | 0.31 | 0.82 | 0.70 | 1.10 | 0.74 | 0.78 |
| 32 | 0.10 | 0.35 | 0.32 | 1.34 | 0.69 | 0.64 | 0.75 | 1.35 |
DISCUSSION
The Indian market is filled with Ayurvedic medicines offered in various forms such as tablets, capsules, granules, syrups, and several others aimed at addressing menstrual irregularities and PCOS. Most of these Ayurvedic products are made using raw herbs. It is crucial to standardize herbal formulations to ensure the quality of the medications. In addition to fundamental testing, identifying and measuring active ingredients, along with the final dosage form, is vital for ensuring consistency from one batch to another. Standardization also plays a significant role in the selection of raw materials, as well as in the processing and production of formulations (Sachan et al., 2016; Attimarad et al., 2011; Garg et al., 2013; Tsering et al., 2014; International Council for Harmonisation [ICH], 2005).
HPTLC is a rapid and accurate method for phytochemical profiling and quantification of compounds in plants. It provides better resolution and estimation of active constituents, allowing for efficient analysis. With the growing demand for herbal medicines and cosmetics, standardization of active raw materials and finished products is essential (Sachan et al., 2016; Attimarad et al., 2011; Garg et al., 2013; Tsering et al., 2014; International Council for Harmonisation [ICH], 2005).
To create a complete formula, we prepare Amarantha Gynorite syrup and Amarantha Gynorite capsules using standard herbal extracts. Analyzing this herbal combination is complex and takes a lot of time and resources, such as infrastructure, manpower, and materials. This research developed a single HPTLC method that is simple, cost-effective, and saves time for analyzing important compounds like Gallic Acid (GA), Vasicine (VS), Pterostilbene (PTS), and Piperine (PP) from both Amarantha Gynorite syrup and capsules.
In the current High-Performance Thin-Layer Chromatography (HPTLC) method, a stationary phase consisting of a precoated silica Gel aluminum plate (G60F254) was selected for the separation of four marker compounds. The individual standards and samples were developed utilizing methanol. Among various mobile phases tested, the optimized mobile phase was determined to be a mixture of toluene, ethyl acetate, formic acid, and Glacial Acetic Acid (GAA) in a volumetric ratio of 2:1:1:0.75, with a detection wavelength established at 280 nm, corresponding to the isosbestic point. The Retention factor (Rf) values for the compounds VS, GA, PP, and PTS were calculated as 0.11, 0.34, 0.68, and 0.71, respectively, as illustrated in Figures 2-4, 10-11.
Linearity was observed across the concentration range of 5-50 μg/mL for the aforementioned compounds, with correlation coefficients falling within acceptable limits. During the accuracy recovery studies, the overall recovery percentages were calculated to be 100.21% for VS, 99.96% for GA, 100.66% for PP, and 99.28% for PTS. The analytical results underwent validation regarding accuracy and precision. The Limits of Detection (LOD) were determined to be 0.662 ng, 1.573 ng, 1.152 ng, and 1.688 ng, while the Limits of Quantification (LOQ) were established as 2.018 ng, 4.769 ng, 3.492 ng, and 5.115 ng for VS, GA, PP, and PTS, respectively.
The precision of the proposed HPTLC method was evaluated through system suitability studies, method precision, intermediate precision, and repeatability assessments, with the percentage Relative Standard Deviation (% RSD) remaining within acceptable criteria of less than 2.0%.
Vasicine, gallic acid, piperine, and pterostilbene were quantitatively measured in the Ayurvedic proprietary formulations, specifically Amarantha Gynorite syrup and Amarantha Gynorite capsules. The developed method proved to be effective for quantifying these marker compounds.
CONCLUSION
A simple and cost-effective method called isocratic HPTLC was created to analyze marker compounds like GA, VS, PTS, and PP from Amarantha Gynorite syrup and capsules. This method is accurate, precise, and reliable. It is also specific and can be easily reproduced.
